This inventor holds 1 USPTO granted patent. Top assignee: Bioneer Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Sung Ll Yun in Fibrotic Disease Treatment
Introduction
Sung Ll Yun is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment of fibrotic diseases and respiratory-related conditions. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Sung Ll Yun holds a patent for a "CTGF GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE, AND A COMPOSITION FOR PREVENTING AND TREATING FIBROTIC DISEASES AND RESPIRATORY-RELATED DISEASES COMPRISING SAME." This patent represents a significant advancement in therapeutic strategies for managing fibrotic diseases.
Career Highlights
He is currently associated with Bioneer Corporation, where he continues to engage in groundbreaking research. His work at Bioneer Corporation has positioned him as a key player in the biotechnology sector, focusing on innovative solutions for complex medical challenges.
Collaborations
Sung Ll Yun collaborates with esteemed colleagues, including Tae-Rim Kim and Han-Oh Park. These partnerships enhance the research and development efforts within his field, fostering a collaborative environment for innovation.
Conclusion
Sung Ll Yun's contributions to medical research, particularly through his patent, highlight his commitment to advancing treatment options for fibrotic diseases. His work exemplifies the impact of innovation in healthcare, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile